Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. Februar 2023 02:00 ET | Quelle: Nodus Oncology

Nodus Oncology Secures £2.4m ($2.9m) Investment

Nodus Oncology Secures £2.4m ($2.9m) Investment KHAN Technology Transfer Fund I (KHAN-I) have invested alongside existing investor Cumulus Oncology Bert Klebl, Managing Director of KHAN-I will join...
08. September 2022 01:15 ET | Quelle: Nodus Oncology

Nodus Oncology announces acquisition of Basilea Pharmaceutica’s PARG inhibitor programme

Nodus Oncology announces acquisition of Basilea Pharmaceutica’s PARG inhibitor programme Acquisition enables Nodus Oncology to continue building its portfolio of first and best-in-class molecules...
06. September 2022 02:00 ET | Quelle: Nodus Oncology

Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets

Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response...